These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

285 related articles for article (PubMed ID: 22407829)

  • 21. Classification of lung cancer.
    Travis WD
    Semin Roentgenol; 2011 Jul; 46(3):178-86. PubMed ID: 21726702
    [No Abstract]   [Full Text] [Related]  

  • 22. Use of the proposals of the international association for the study of lung cancer in the forthcoming edition of lung cancer staging system to predict long-term prognosis of operated patients.
    Rena O; Massera F; Robustellini M; Papalia E; Delfanti R; Lisi E; Pirondini E; Turello D; Casadio C
    Cancer J; 2010; 16(2):176-81. PubMed ID: 20404615
    [TBL] [Abstract][Full Text] [Related]  

  • 23. [Lung cancer in smokers and never-smokers].
    Helland A; Brustugun OT
    Tidsskr Nor Laegeforen; 2009 Sep; 129(18):1859-62. PubMed ID: 19844277
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Establishment and comparative characterization of novel squamous cell non-small cell lung cancer cell lines and their corresponding tumor tissue.
    Gottschling S; Jauch A; Kuner R; Herpel E; Mueller-Decker K; Schnabel PA; Xu EC; Muley T; Sültmann H; Bender C; Granzow M; Efferth T; Hoffmann H; Dienemann H; Herth FJ; Meister M
    Lung Cancer; 2012 Jan; 75(1):45-57. PubMed ID: 21684623
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Aberrant expression of p53 or the epidermal growth factor receptor is frequent in early bronchial neoplasia and coexpression precedes squamous cell carcinoma development.
    Rusch V; Klimstra D; Linkov I; Dmitrovsky E
    Cancer Res; 1995 Mar; 55(6):1365-72. PubMed ID: 7882337
    [TBL] [Abstract][Full Text] [Related]  

  • 26. [Grading of lung cancer].
    Bohle RM; Schnabel PA
    Pathologe; 2016 Jul; 37(4):314-9. PubMed ID: 27356985
    [TBL] [Abstract][Full Text] [Related]  

  • 27. [Clinicopathological characteristics of lung cancers 2 cm or less in diameter].
    Mano M
    Nihon Rinsho; 2002 May; 60 Suppl 5():557-60. PubMed ID: 12101735
    [No Abstract]   [Full Text] [Related]  

  • 28. Comprehensive histologic analysis of ALK-rearranged lung carcinomas.
    Yoshida A; Tsuta K; Nakamura H; Kohno T; Takahashi F; Asamura H; Sekine I; Fukayama M; Shibata T; Furuta K; Tsuda H
    Am J Surg Pathol; 2011 Aug; 35(8):1226-34. PubMed ID: 21753699
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Prognostic value of expression of vascular endothelial growth factor and its flt-1 and KDR receptors in stage I non-small-cell lung cancer.
    Seto T; Higashiyama M; Funai H; Imamura F; Uematsu K; Seki N; Eguchi K; Yamanaka T; Ichinose Y
    Lung Cancer; 2006 Jul; 53(1):91-6. PubMed ID: 16697074
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Biologic effects of radiofrequency thermal ablation on non-small cell lung cancer: results of a pilot study.
    Ambrogi MC; Fontanini G; Cioni R; Faviana P; Fanucchi O; Mussi A
    J Thorac Cardiovasc Surg; 2006 May; 131(5):1002-6. PubMed ID: 16678582
    [TBL] [Abstract][Full Text] [Related]  

  • 31. [The natural history of lung cancer].
    Miyamoto H; Kawakami Y
    Kokyu To Junkan; 1988 Sep; 36(9):961-7. PubMed ID: 2853436
    [No Abstract]   [Full Text] [Related]  

  • 32. Adjuvant systemic therapy of lung cancer.
    Muggia FM; McGuire WP
    Cancer Clin Trials; 1978; 1(3):235-41. PubMed ID: 229981
    [TBL] [Abstract][Full Text] [Related]  

  • 33. The 3' UTR IGF2R-A2/B2 variant is associated with increased tumor growth and advanced stages in non-small cell lung cancer.
    Kotsinas A; Evangelou K; Sideridou M; Kotzamanis G; Constantinides C; Zavras AI; Douglass CW; Papavassiliou AG; Gorgoulis VG
    Cancer Lett; 2008 Feb; 259(2):177-85. PubMed ID: 18037232
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Long-term survivors of non-small cell lung cancer after radiation therapy: the significance of histological type.
    Nakayama Y; Hayakawa K; Mitsuhashi N; Saito Y; Niibe H
    Anticancer Res; 1997; 17(4A):2769-73. PubMed ID: 9252713
    [TBL] [Abstract][Full Text] [Related]  

  • 35. [Surgical limitations and combination therapy in progressive lung cancer. Histological types and cancerous growth].
    HPAYADA Y
    Nihon Kyobu Geka Gakkai Zasshi; 1977 May; 25(5):641-3. PubMed ID: 925419
    [No Abstract]   [Full Text] [Related]  

  • 36. [Treatment based on biological characteristics of lung cancer: biological differences between small cell and non-small cell lung cancer and gene therapy].
    Tanio Y
    Gan To Kagaku Ryoho; 1997 Oct; 24 Suppl 3():337-44. PubMed ID: 9369905
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Expression of cell proliferating genes in patients with non-small cell lung cancer by immunohistochemistry and cDNA profiling.
    Mao Y; Wu J; Skog S; Eriksson S; Zhao Y; Zhou J; He Q
    Oncol Rep; 2005 May; 13(5):837-46. PubMed ID: 15809747
    [TBL] [Abstract][Full Text] [Related]  

  • 38. [The clinical significance of biological characters on non-small cell lung cancer].
    Liao M; Lin Z; Zhou Y
    Zhonghua Jie He He Hu Xi Za Zhi; 1998 Jan; 21(1):30-3. PubMed ID: 11263297
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Receptor tyrosine kinase alterations and therapeutic opportunities in squamous cell carcinoma of the lung.
    Wang D; Du L; Liu Q; Liu X; Wang Z
    Cancer Chemother Pharmacol; 2013 Oct; 72(4):725-31. PubMed ID: 23959461
    [TBL] [Abstract][Full Text] [Related]  

  • 40. [Advances on driver oncogenes of squamous cell lung cancer].
    Hong W; Zhang Y
    Zhongguo Fei Ai Za Zhi; 2014 May; 17(5):433-6. PubMed ID: 24854563
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 15.